The weekly litigation news digest is live. Subscribe now

IP Verse

Heterocyclic Compound - EP3782986

The patent EP3782986 was granted to Takeda Pharmaceutical on Jul 10, 2024. The application was filed on Mar 28, 2019 under application number EP19774394A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3782986

TAKEDA PHARMACEUTICAL
Application Number
EP19774394A
Filing Date
Mar 28, 2019
Status
Granted And Under Opposition
Jun 7, 2024
Publication Date
Jul 10, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
DE CLERCQ & PARTNERSApr 10, 2025DE CLERCQ & PARTNERSADMISSIBLE

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONJP2007091649
DESCRIPTIONUS2009143302
DESCRIPTIONWO2011012661
DESCRIPTIONWO2012066065
DESCRIPTIONWO2012101065
DESCRIPTIONWO2015058140
DESCRIPTIONWO2016058544
DESCRIPTIONWO9931072
INTERNATIONAL-SEARCH-REPORTJP2016533379
INTERNATIONAL-SEARCH-REPORTWO2016142855
INTERNATIONAL-SEARCH-REPORTWO2016193939
OPPOSITIONWO2006035967
OPPOSITIONWO2011012661
OPPOSITIONWO2015058140
OPPOSITIONWO2016058544
SEARCHEP1464335

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents